28 May, 2019
Cuba Decreases Amputations by Using Heberprot-P
Treatment with Heberprot-P has decreased the risk of patients’ amputation with diabetic foot ulcers by 71 percent among Cuban population, assured Manuel Raices, from the Center of Genetic Engineering and Biotechnology.